Requirement for CDK4 kinase function in breast cancer.

Area of Science:

• Oncology and Molecular Biology

Background:

• Cyclin D1 overexpression is common in human breast cancers.
• Mice lacking cyclin D1 show resistance to ErbB-2 oncogene-driven mammary tumors.

Purpose of the Study:

• To determine the specific function of cyclin D1 essential for ErbB-2-driven breast cancer.
• To investigate the role of cyclin D1-CDK4 kinase activity in mammary oncogenesis.

Main Methods:

• Analysis of cyclin D1 function in ErbB-2-driven mammary oncogenesis in mice.
• Assessment of CDK4-associated kinase activity in tumor maintenance.
• Examination of cyclin D1 levels in human breast cancer samples.

Main Results:

• Cyclin D1's ability to activate cyclin-dependent kinase 4 (CDK4) is critical for breast cancer formation.
• Sustained CDK4 kinase activity is necessary for maintaining established breast tumors.
• Approximately 25% of ErbB-2-overexpressing human breast cancers exhibit high cyclin D1 levels.

Conclusions:

• The cyclin D1-CDK4 kinase complex is a key driver of ErbB-2-induced breast cancer.
• Targeting CDK4 kinase activity may be a therapeutic strategy for a subset of breast cancer patients.